Algernon Pharmaceuticals (TSE:AGN) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Algernon Pharmaceuticals, a Canadian clinical stage drug development company, has announced an increase in its non-brokered private placement from $250,000 to $408,000, with each unit consisting of a common share and a purchase warrant. The offering is set to close on August 1, 2024, and the proceeds will be used for working capital purposes. The warrants have an accelerated expiry clause if the company’s share price exceeds certain thresholds.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.
